次世代シーケンシングインフォマティクス市場-世界の産業規模、シェア、動向、競合、機会、予測、製品・サービス別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

次世代シーケンシング（NGS）インフォマティクスの世界市場は、2024年に54億8,000万米ドルと評価され、2030年までには187億4,000万米ドルに達し、CAGR22.74％で成長すると予測されています。

がん罹患率の増加とNGSの臨床応用の拡大により、市場は大幅な成長を遂げています。2020年、Global Cancer Observatoryは、乳がん、肺がん、大腸がん、前立腺がん、胃がんなど、1,900万人以上の新たながん罹患を記録しました。市場の拡大に寄与しているのは、DNAシーケンシングサンプル数の増加、シーケンシングコストの低下、政府のゲノム関連イニシアティブ、従来のマイクロアレイ技術に対するNGSの採用拡大です。シーケンス解析がより安価になり、疾患の診断と治療に不可欠になるにつれ、大規模ゲノムデータの管理、解析、解釈が可能な堅牢なインフォマティクスプラットフォームに対する需要は拡大し続けています。

主要な市場促進要因

プレシジョンメディシンとゲノムに基づく診断の採用増加

主要な市場動向

NGSインフォマティクスにおける人工知能と機械学習の統合

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の次世代シーケンシング（NGS）インフォマティクス市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品・サービス別（ストレージ・コンピューティングツール、商用データ分析、データ解釈・レポートツール、次世代シーケンシング（NGS）インフォマティクスサービス、ラボ情報管理システム（LIMS））
  • 用途別（創薬、遺伝子スクリーニング、疾患診断など）
  • エンドユーザー別（病院、診断センター、製薬・バイオテクノロジー企業、学術・研究機関）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 市場マップ
  • 製品とサービス別
  • 用途別
  • エンドユーザー別
  • 地域別

第6章 北米の次世代シーケンシング（NGS）インフォマティクス市場の展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の次世代シーケンシング（NGS）インフォマティクス市場の展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の次世代シーケンシング（NGS）インフォマティクス市場の展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア

第9章 南米の次世代シーケンシング（NGS）インフォマティクス市場の展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの次世代シーケンシング（NGS）インフォマティクス市場の展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第14章 世界の次世代シーケンシング（NGS）インフォマティクス市場：SWOT分析

第15章 競合情勢

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 billion in 2024 and is projected to reach USD 18.74 billion by 2030, growing at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.

Key Market Drivers

Rising Adoption of Precision Medicine and Genomic-Based Diagnostics

The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH's "All of Us Research Program" reflect this trend, collecting genetic data from over one million participants-over 600,000 of whom had enrolled by 2023. This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in NGS Informatics

The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU's Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.

Key Market Players

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

Report Scope:

In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Product & Services:

• Storage and Computing Tools
• Commercial Data Analysis
• Data Interpretation and Reporting Tools
• Next Generation Sequencing (NGS) Informatics Services
• Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
  • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
  • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Products & Services
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products & Services
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products & Services
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
      • 7.3.1.2.4. By Country
  • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products & Services
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products & Services
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products & Services
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Next Generation Sequencing (NGS) Informatics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd.
• 15.3. PerkinElmer, Inc.
• 15.4. SOPHiA GENETICS SA
• 15.5. Precigen, Inc.
• 15.6. QIAGEN N.V.
• 15.7. Illumina, Inc.
• 15.8. Agilent Technologies, Inc.
• 15.9. Eagle Genomics Limited
• 15.10. BGI Genomics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer